UNSPSC 51381800: Nonsteroidal anti inflammatory acetates

Nonsteroidal anti inflammatory drugs made from derivatives of acetic acid, hence the name ACETATES; these may include acid forms, salts, esters, and amides that contain the carboxymethane structure.

UNSPSC 51381800 Nonsteroidal anti inflammatory acetates is a Class code that in state and local practice spans the procurement of pharmaceutical products and medical supplies for community health programs. The recent record shows minimal activity aligned with the code's nominal scope; the single identified opportunity involves naloxone and drug deactivation systems—opioid-reversal agents and harm-reduction equipment—which fall outside the nonsteroidal anti-inflammatory acetate category and suggest either misclassification by the issuing body or a narrow application of this code in state and local purchasing. State and local health departments and county public health agencies appear to be the primary users of this code when it does see procurement activity.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems for delivery to the Seminole County Community Health Building, with quarterly delivery cycles and a two-year initial contract term plus one-year renewal option. The IFB required electronic bid submission through the county's e-Procurement Portal, with response deadline of July 26, 2023, at 2:00 pm, and mandated E-Verify compliance, drug-free workplace certification, workers' compensation, commercial general liability insurance, and adherence to federal environmental regulations (Clean Air Act, Federal Water Pollution Control Act) owing to potential FEMA funding. No explicit set-aside designations were noted. This code shows limited recent state and local activity; bidders should verify actual category alignment with issuing agencies before pursuit, as the single opportunity identified reflects a mismatch between the code's pharmaceutical classification and the harm-reduction equipment actually being bought.